Endometrial stromal tumors: immunohistochemical and molecular analysis of potential targets of tyrosine kinase inhibitors

BACKGROUND: The systemic treatment of malignant endometrial stromal tumors (EST) is not well established. A few reports describe objective responses to imatinib, which suggest a novel therapeutic strategy for these tumors. Due to these facts, we aimed to perform a retrospective analysis of possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Sardinha, Ruth, Hernández, Teresa, Fraile, Susana, Tresserra, Francesc, Vidal, August, Gómez, Maria Carmén, Astudillo, Aurora, Hernández, Nieves, Saenz de Santamaría, Javier, Ordi, Jaume, Gonçalves, Luis, Ramos, Rafael, Balañá, Carmen, de Álava, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599876/
https://www.ncbi.nlm.nih.gov/pubmed/23497641
http://dx.doi.org/10.1186/2045-3329-3-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599876/
https://www.ncbi.nlm.nih.gov/pubmed/23497641
http://dx.doi.org/10.1186/2045-3329-3-3

Ejemplares similares